Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation

European Journal of Pharmaceutical Sciences

Volumn 35, Issue 1-2, 2008, Pages 19-29

  Cafaggi, S ^a   Russo, E ^a   Caviglioli, G ^a   Parodi, B ^a   Stefani, R ^a   Sillo, G ^a   Leardi, R ^a   Bignardi, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Gel; Mixture design; Phase solubility; Poloxamer 407; Release; Tetrahydrofurfuryl alcohol; Tolfenamic acid

Indexed keywords

ALCOHOL; MYRISTIC ACID ISOPROPYL ESTER; POLOXAMER; SOLUBILIZER; TOLFENAMIC ACID;

AQUEOUS SOLUTION; ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EXPERIMENTAL DESIGN; GEL; MICELLE; PRIORITY JOURNAL; SOLUBILIZATION; SUSTAINED DRUG RELEASE;

ALGORITHMS; ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GELS; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MYRISTATES; POLOXAMER; REGRESSION ANALYSIS; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM; SURFACE-ACTIVE AGENTS; THERMODYNAMICS; VISCOSITY;

EID: 48849096341     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.05.010     Document Type: Article

References (47)

1. Abdelrahim M., Baker C.H., Abbruzzese J.L., and Safe S. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. J. Natl. Cancer Inst. 98 (2006) 855-868
2. Alexandridis P., and Hatton T.A. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block-copolymer surfactants in aqueous-solutions and at interfaces - thermodynamics, structure, dynamics, and modeling. Colloid. Surf. A - Physicochem. Eng. Aspects 96 (1995) 1-46
3. Alexandridis P., Ivanova R., and Lindman B. Effect of glycols on the self-assembly of amphiphilic block copolymers in water. 2. Glycol location in the microstructure. Langmuir 16 (2000) 3676-3689
4. Belyakova A., Vainshtein V., Markova K., Demchenko Y., and Chibilyaev T. Extraction of nettle leaves using synthetic esters of fatty acids. Pharm. Chem. J. 39 (2005) 598-602
5. Cafaggi S., Leardi R., Parodi B., Caviglioli G., and Bignardi G. An example of application of a mixture design with constraints to a pharmaceutical formulation. Chemom. Intell. Lab. Syst. 65 (2003) 139-147
6. ®F127 gels. Int. J. Pharm. 8 (1981) 89-99
7. Chi S.C., and Jun H.W. Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell. J. Pharm. Sci. 80 (1991) 280-283
8. Chiappetta D.A., and Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm. Biopharm. 66 (2007) 303-317
9. Choi H.G., Lee M.K., Kim M.H., and Kim C.K. Effect of additives on the physicochemical properties of liquid suppository bases. Int. J. Pharm. 190 (1999) 13-19
10. Cook R.D., and Nachtsheim C.J. A comparison of algorithms for constructing exact d-optimal designs. Technometrics 22 (1980) 315-324
11. Dumortier G., Grossiord J.L., Agnely F., and Chaumeil J.C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 23 (2006) 2709-2728
12. Gilpin R.K., and Zhou W. Infrared studies of the polymorphic states of the fenamates. J. Pharm. Biomed. Anal. 37 (2005) 509-515
13. Higuchi T., and Connors K.A. Phase solubility techniques. Adv. Anal. Chem. Instrum. 4 (1965) 117-212
14. Higuchi W.I. Analysis of data on medicament release from ointments. J. Pharm. Sci. 51 (1962) 802-804
15. Ivanova R., Lindman B., and Alexandridis P. Effect of glycols on the self-assembly of amphiphilic block copolymers in water. 1. Phase diagrams and structure identification. Langmuir 16 (2000) 3660-3675
16. Ivanova R., Alexandridis P., and Lindman B. Interaction of poloxamer block copolymers with cosolvents and surfactants. Colloid. Surf. A: Phys. Eng. Aspects 183-185 (2001) 41-53
17. Ivanova R., Lindman B., and Alexandridis P. Effect of pharmaceutically acceptable glycols on the stability of the liquid crystalline gels formed by poloxamer 407 in water. J. Colloid Interface Sci. 252 (2002) 226-235
18. Jankun J., Selman S.H., Aniola J., and Skrzypczak-Jankun E. Nutraceutical inhibitors of urokinase: potential applications in prostate cancer prevention and treatment. Oncol. Rep. 16 (2006) 341-346
19. Kabanov A.V., Batrakova E.V., Meliknubarov N.S., Fedoseev N.A., Dorodnich T.Y., Alakhov V.Y., Chekhonin V.P., Nazarova I.R., and Kabanov V.A. A new class of drug carriers - micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain. J. Contr. Rel. 22 (1992) 141-157
20. Kovala-Demertzi D. Recent advances on non-steroidal anti-inflammatory drugs, NSAIDs: organotin complexes of NSAIDs. J. Organomet. Chem. 691 (2006) 1767-1774
21. Kovala-Demertzi D., Galani A., Demertzis M.A., Skoulika S., and Kotoglou C. Binuclear copper(II) complexes of tolfenamic: synthesis, crystal structure, spectroscopy and superoxide dismutase activity. J. Inorg. Biochem. 98 (2004) 358-364
22. Kovala-Demertzi D., Kourkoumelis N., Koutsodimou A., Moukarika A., Horn E., and Tiekink E.R.T. Synthesis and spectroscopic studies of diorganotin derivatives with tolfenamic acid. Crystal and molecular structure of the first complex of tolfenamic acid, 1,2: 3,4-di-mu(2)-2-[(3-chloro-2-methylphenyl)amino]-benzoato-O,O-1,3-bis-2-[(3-chloro-2-methylphenyl)amino]-benzoato-O-1,2,4: 2,3,4-di-mu(3)-oxo-tetrakis[di-n-butyltin(IV)]. J. Organomet. Chem. 620 (2001) 194-201
23. Lashmar U.T., Hadgraft J., and Thomas N. Topical application of penetration enhancers to the skin of nude mice: a histopathological study. J. Pharm. Pharmacol. 41 (1989) 118-121
24. Lin S.Y., and Kawashima Y. The influence of three poly(oxyethylene)poly (oxypropylene) surface-active block copolymers on the solubility behavior of indomethacin. Pharm. Acta Helv. 60 (1985) 339-344
25. Lizarraga I., and Chambers J.P. Involvement of opioidergic and alpha(2)-adrenergic mechanisms in the central analgesic effects of non-steroidal anti-inflammatory drugs in sheep. Res. Vet. Sci. 80 (2006) 194-200
26. Lu G.W., and Jun H.W. Diffusion studies of methotrexate in carbopol and poloxamer gels. Int. J. Pharm. 160 (1998) 1-9
27. Mao Y., Thompson M.J., Wang Q.X., and Tsai E.W. Quantitation of poloxamers in pharmaceutical formulations using size exclusion chromatography and colorimetric methods. J. Pharm. Biomed. Anal. 35 (2004) 1127-1142
28. Pandit N.K., and Kisaka J. Loss of gelation ability of Pluronic(R) F127 in the presence of some salts. Int. J. Pharm. 145 (1996) 129-136
29. Pandit N.K., and McIntyre H.J. Cosolvent effects on the gel formation and gel melting transitions of Pluronic F127 gels. Pharm. Dev. Technol. 2 (1997) 181-184
30. Pandit N.K., and Wang D. Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels. Int. J. Pharm. 167 (1998) 183-189
31. Pedersen S.B. Biopharmaceutical aspects of tolfenamic acid. Pharmacol. Toxicol. 75 (1994) 22-32
32. Peppas N.A. Analysis of Fickian and non-Fickian drug release polymers. Pharm. Acta Helv. 60 (1985) 110-111
33. Polasek M., Pospisilova M., and Urbanek M. Capillary isotachophoretic determination of flufenamic, mefenamic, niflumic and tolfenamic acid in pharmaceuticals. J. Pharm. Biomed. Anal. 23 (2000) 135-142
34. Poulsen B.J., Young E., Coquilla V., and Katz M. Effect of topical vehicle composition on the in vitro release of fluocinolone. J. Pharm. Sci. 57 (1968) 923-928
35. Ricci E.J., Lunardi L.O., Nanclares D.M.A., and Marchetti J.M. Sustained release of lidocaine from Poloxamer 407 gels. Int. J. Pharm. 288 (2005) 235-244
36. Rozou S., Michaelas S., and Antoniadou-Vyza E. Supramolecular interactions between tolfenamic acid and various cyclodextrins: effects of complexation on physicochemical and spectroscopic data. Pharm. Pharmacol. Commun. 5 (1999) 79-84
37. Rozou S., Michaleas S., and Antoniadou-Vyza E. Study of structural features and thermodynamic parameters, determining the chromatographic behaviour of drug-cyclodextrin complexes. J. Chromatogr. A 1087 (2005) 86-94
38. Schmolka I.R. Artificial skin, I. Preparation and properties of Pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res. 6 (1972) 571-582
39. Sidhu P.K., Landoni M.F., and Lees P. Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats. Res. Vet. Sci. 80 (2006) 79-90
40. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48 (2001) 139-157
41. Stolnik S., Felumb N.C., Heald C.R., Garnett M.C., Illum L., and Davis S.S. Adsorption behaviour and conformation of selected poly(ethylene oxide) copolymers on the surface of a model colloidal drug carrier. Colloid. Surf. A: Phys. Eng. Aspects 122 (1997) 151-159
42. Suh H., and Jun H.W. Physicochemical and release studies of naproxen in poloxamer gels. Int. J. Pharm. 129 (1996) 13-20
43. Thybo P., Kristensen J., and Hovgaard L. Characterization and physical stability of tolfenamic Acid-PVP K30 solid dispersions. Pharm. Dev. Technol. 12 (2007) 43-53
44. Vaution C., Treiner C., Puisieux F., and Carstensen J.T. Solubility behavior of barbituric acids in aqueous solution of sodium alkyl sulfonate as a function of concentration and temperature. J. Pharm. Sci. 70 (1981) 1238-1242
45. Wurster D.E., and Taylor P.W. Dissolution kinetics of certain crystalline forms of prednisolone. J. Pharm. Sci. 54 (1965) 670-676
46. Zhang L., Parsons D.L., Navarre C., and Kompella U.B. Development and in-vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur. J. Contr. Rel. 85 (2002) 73-81
47. Ziakas G.N., Rekka E.A., Gavalas A.M., Eleftheriou P.T., Tsiakitzis K.C., and Kourounakis P.N. Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile. Bioorg. Med. Chem. 13 (2005) 6485-6492